Item | Value |
Females: n (%) | 45 (82) |
Age: median (IQR) | 52 (45–59) |
Primary immune-mediated disease: n (%) | |
Connective tissue diseases | 15 (27) |
Systemic lupus erythematosus | 11 (20) |
Systemic sclerosis | 1 (2) |
Sjoegren’s syndrome | 1 (2) |
Undifferentiated connective tissue disease | 2 (4) |
Arthritides | 19 (35) |
Rheumatoid arthritis | 13 (24) |
Inflammatory spondyloarthropathies | 4 (7) |
Other | 2 (4) |
Systemic vasculitides | 8 (15) |
Large-vessel vasculitides | 2 (4) |
Small-vessel vasculitides | 3 (5) |
Other | 3 (5) |
Autoinflammatory diseases | |
Adult-onset Still’s disease | 1 (2) |
Primary immunodeficiencies | 3 (5) |
IgG4-related disease | 7 (13) |
Sarcoidosis | 1 (2) |
Other | 1 (2) |
Immune-mediated comorbidities: n (%) | |
Allergy | 22 (40) |
Drugs | 17 (31) |
Food | 8 (15) |
Inhalants | 3 (5) |
Hymenopter venom | 1 (2) |
Asthma | 5 (9) |
Chronic urticaria | 7 (13) |
Mastocytosis | 0 (0) |
Allergy | 22 (40) |
Other comorbidities*: n (%) | |
Hypertension | 8 (15) |
Cardiovascular diseases | 4 (7) |
Cancer | 2 (4) |
Having received organ transplants | 1 (2) |
Metabolic/endocrine disorders | 17 (31) |
Obesity/overweight | 2 (4) |
Hypothyroidism | 6 (11) |
Dyslipidaemia | 5 (9) |
Diabetes | 4 (7) |
Osteoporosis | 3 (5) |
Renal diseases | 3 (5) |
Neurological disorders | 3 (5) |
Gastrointestinal disorders | 9 (16) |
Upper airway diseases | 4 (7) |
Other | 2 (4) |
Previous COVID-19 | 6 (11) |
*Immune-mediated disorders causing organ dysfunction (eg, Hashimoto’s thyroiditis for ‘hypothyroidism’ or coeliac disease for ‘gastrointestinal disorders’) are scored twice.